Cargando…

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients

BACKGROUND: Approximately 60% of patients with colorectal cancer (CRC) undergo either local recurrence or distant metastases after surgery. Current prognostic biomarkers are insufficient to predict recurrence of CRC and provide little forecast information about what patients are likely to receive be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Dengbo, Qiao, Meng, Yao, Yunfeng, Li, Ming, Chen, Hailong, Dong, Qi, Jia, Jinying, Cui, Xinxin, Li, Zhaowei, Xia, Jinhong, Gu, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156709/ https://www.ncbi.nlm.nih.gov/pubmed/30166271 http://dx.doi.org/10.1016/j.ebiom.2018.08.042

Ejemplares similares

FAP promotes metastasis and chemoresistance via regulating YAP1 and macrophages in mucinous colorectal adenocarcinoma
por: Ji, Dengbo, et al.
Publicado: (2023)

MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1
por: Ji, Dengbo, et al.
Publicado: (2014)

Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer
por: Ji, Dengbo, et al.
Publicado: (2018)

Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer
por: Ji, Dengbo, et al.
Publicado: (2020)

UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer
por: Shi, Mengyuan, et al.
Publicado: (2023)

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis
por: Wang, Yun, et al.
Publicado: (2021)

A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response
por: Zheng, Yi, et al.
Publicado: (2015)

A panel of microRNA signature in serum for colorectal cancer diagnosis
por: Zhu, Mingxia, et al.
Publicado: (2017)

Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection
por: Wang, Jia, et al.
Publicado: (2014)

A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy
por: Bi, Nan, et al.
Publicado: (2014)

A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
por: Lu, Jia-huan, et al.
Publicado: (2018)

Adjuvant chemotherapy for colorectal cancer
por: Maughan, T S
Publicado: (2001)

MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis
por: Zhang, Xi, et al.
Publicado: (2022)

Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers
por: Ishida, Kazushige, et al.
Publicado: (2012)

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
por: Okuno, Keisuke, et al.
Publicado: (2023)

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
por: Herreros-Villanueva, Marta, et al.
Publicado: (2019)

MicroRNA signatures and Foxp3(+) cell count correlate with relapse occurrence in follicular lymphoma
por: Malpeli, Giorgio, et al.
Publicado: (2018)

Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer
por: Yang, Yongmei, et al.
Publicado: (2020)

A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer
por: Tian, Xianglong, et al.
Publicado: (2020)

Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2013)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
por: Glimelius, Bengt, et al.
Publicado: (2020)

Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer
por: Di, Ziyang, et al.
Publicado: (2020)

A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer
por: Cao, Bangrong, et al.
Publicado: (2017)

Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
por: Varela-Martínez, Endika, et al.
Publicado: (2018)

Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
por: Bergsland, Christian H, et al.
Publicado: (2020)

Plasma‐based microRNA signatures in early diagnosis of breast cancer
por: Li, Xu, et al.
Publicado: (2020)

The Role of MicroRNA Signature as Diagnostic Biomarkers in Different Clinical Stages of Colorectal Cancer
por: Eslamizadeh, Sara, et al.
Publicado: (2018)

A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis
por: Yang, Guodong, et al.
Publicado: (2019)

MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance
por: Baharudin, Rashidah, et al.
Publicado: (2022)

Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients
por: Yang, I-Ping, et al.
Publicado: (2016)

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
por: Dalmasso, Bruna, et al.
Publicado: (2018)

The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation
por: Yan, Qiuliang, et al.
Publicado: (2020)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Hanyang, et al.
Publicado: (2022)

MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers
por: Choi, Yong Won, et al.
Publicado: (2016)

Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer
por: Chen, Maoshan, et al.
Publicado: (2019)

A Six-microRNA Signature Nomogram for Preoperative Prediction of Tumor Deposits in Colorectal Cancer
por: Xiao, Shihan, et al.
Publicado: (2022)

The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?
por: Wang, Yun, et al.
Publicado: (2017)

Friend or foe: the role of microRNA in chemotherapy resistance
por: Li, Haoran, et al.
Publicado: (2013)

Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer
por: Pattison, Sharon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8imm8ila42f62ihrma3vlecej0